KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Liabilities and Shareholders Equity (2019 - 2025)

Clover Health Investments' Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $541.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 6.84% year-over-year to $541.0 million; the TTM value through Dec 2025 reached $2.3 billion, up 16.37%, while the annual FY2025 figure was $541.0 million, 6.84% down from the prior year.
  • Liabilities and Shareholders Equity reached $541.0 million in Q4 2025 per CLOV's latest filing, down from $559.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2022 to a low of $354.7 million in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $876.9 million, with a median of $634.3 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 133094.34% in 2021, then tumbled 72.48% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $950.8 million in 2021, then tumbled by 62.69% to $354.7 million in 2022, then soared by 60.87% to $570.7 million in 2023, then grew by 1.76% to $580.7 million in 2024, then decreased by 6.84% to $541.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Liabilities and Shareholders Equity are $541.0 million (Q4 2025), $559.7 million (Q3 2025), and $575.0 million (Q2 2025).